awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24195003-824427AE-85AC-4F82-A24A-C6417694005A
Q24195003-824427AE-85AC-4F82-A24A-C6417694005A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24195003-824427AE-85AC-4F82-A24A-C6417694005A
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
P2860
Q24195003-824427AE-85AC-4F82-A24A-C6417694005A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24195003-824427AE-85AC-4F82-A24A-C6417694005A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
57abfc488c93f0f589f95872593bd89ce0f29921
P2860
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review.